WikiMD is the world's largest medical encyclopedia with
13,947 pages, 4,144,401 edits & 41,644,046 views.
ASK1 inhibitor GS-4997
An orally bioavailable inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with potential anti-inflammatory, antineoplastic and anti-fibrotic activities. Upon oral administration, ASK1 inhibitor GS-4997 targets and binds to the catalytic kinase domain of ASK1 in an ATP-competitive manner, thereby preventing its phosphorylation and activation. This prevents the phosphorylation of downstream kinases, such as c-Jun N-terminal kinases (JNKs) and p38 mitogen-activated protein kinase (p38 MAPK). By preventing the activation of ASK1-dependent signal transduction pathways, GS-4997 prevents the production of inflammatory cytokines, down-regulates the expression of genes involved in fibrosis, suppresses excessive apoptosis and inhibits cellular proliferation. ASK1, also called mitogen-activated protein kinase kinase kinase 5 (MAP3K5), is activated in response to oxidative and endoplasmic reticulum (ER) stress, calcium influx and infection. It plays a key role in the development of certain cardiovascular and neurodegenerative diseases, diabetes, as well as certain types of cancer.
Learn more about ASK1 inhibitor GS-4997
- Dailymed label info
- Scientific articles
- Drug portal ASK1 inhibitor GS-4997
- toxicity info on ASK1 inhibitor GS-4997
- FDA ASK1 inhibitor GS-4997
Latest research - ASK1 inhibitor GS-4997
External links
This WikiMD article ASK1 inhibitor GS-4997 is a stub. If you are familiar with the topic ASK1 inhibitor GS-4997, you can help us. Paid editors welcome!
ASK1 inhibitor GS-4997 is part of WikiMD's free ^articles!
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
 Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available |
